Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
32 33 Next >
Expert Ratings for Biogen
Tickers BIIB
Tags BZI/AAR Benzinga BIIB
From Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
Tickers BIIB ESALF ESALY
Tags Health Care BIIB Biotech
From Benzinga
Thinking Of Buying Boston Properties? Here Are The Properties And Tenants You'd Add To Your Portfolio
Tickers AKAM BIIB BXP CRM
Tags Alternative investments REIT SLG
From Benzinga
Biogen and Denali Realign Parkinson's Disease Research Priorities Amidst R&D Restructure
Tickers BIIB DNLI
Tags Briefs News Biotech
From Benzinga
Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.
Tickers ABBV ALNY AMGN ARGX
Tags GSK NVS SPX
From MarketWatch
$100 Invested In Biogen 15 Years Ago Would Be Worth This Much Today
Tickers BIIB
Tags Benzinga BIIB Dividends
From Benzinga
Medicare unveils plan for coverage of new Alzheimer’s drugs
Tickers BIIB ESALF LLY
Tags ESALF BIIB LLY
From MarketWatch
Biogen Unusual Options Activity For May 26
Tickers BIIB
Tags BIIB Benzinga Options
From Benzinga
New Alzheimer’s drug could bring hope to patients, but could be out of reach for people on Medicare
Tickers BIIB
Tags BIIB JP:4523
From MarketWatch
Analyst Ratings for Biogen
Tickers BIIB
Tags BZI/AAR Benzinga BIIB
From Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $5,500 Today
Tickers BIIB
Tags Earnings Market News News
From Benzinga
3 Biotech Stocks That Are Revolutionizing Healthcare in 2023
Tickers BIIB CRSP IMGN VRTX
Tags NASDAQ:BIIB,NASDAQ:VRTX,NASDAQ:CRSP,NASDAQ:IMGN VRTX CRSP
From InvestorPlace
1 Major Advantage Biogen May Have Over Pharma Giant Eli Lilly in a Multibillion-Dollar Market
Tickers BIIB LLY
Tags Market News LLY Recent Press Releases
From Motley Fool
These 2 Pharma Stocks Might Face Off Soon -- but They Could Both Win
Tickers BIIB LLY
Tags Recent Press Releases BIIB LLY
From Motley Fool
3 Reasons to Buy Biogen Stock (and 1 to Sell)
Tickers BIIB
Tags Market News Recent Press Releases BIIB
From Motley Fool
Here’s What Eli Lilly’s Latest Clinical Win Means For Investors
Tickers BIIB LLY
Tags BIIB Recent Press Releases LLY
From Motley Fool
Here's Why Eli Lilly's Alzheimer's Drug Could Be the Real Deal
Tickers BIIB LLY
Tags Market News Recent Press Releases BIIB
From Motley Fool
(BIIB) - Analyzing Biogen's Short Interest
Tickers BIIB
Tags Trading Ideas Short Sellers Benzinga
From Benzinga
Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance
Tickers AZN BIIB KRTX NVS
Tags Markets General RPRX
From Benzinga
P/E Ratio Insights for Biogen
Tickers BIIB
Tags BIIB BZI/PE News
From Benzinga
Biogen Unusual Options Activity
Tickers BIIB
Tags Markets BZI/UOA Market News
From Benzinga
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
Tickers BIIB ESALF ESALY LLY
Tags Expert Ideas Analyst Color ESALF
From Benzinga
$1000 Invested In Biogen 15 Years Ago Would Be Worth This Much Today
Tickers BIIB
Tags News Earnings Market News
From Benzinga
Eli Lilly’s positive results from a Alzheimer’s trial seen as ‘potentially very important’
Tickers BIIB LLY
Tags LLY JP:4523 BIIB
From MarketWatch
Why Eli Lilly Stock Is Bolting Higher Today
Tickers BIIB LLY
Tags Market News Recent Press Releases BIIB
From Motley Fool
Biogen Unusual Options Activity For May 03
Tickers BIIB
Tags Market News Markets BZI/UOA
From Benzinga
Microsoft, Snap And 2 Other Stocks Insiders Are Selling
Tickers BIIB MSFT REXR SNAP
Tags Market News Short Ideas Markets
From Benzinga
Eli Lilly stock jumps 8% after Alzheimer’s treatment slows disease progression in major trial
Tickers BIIB LLY SPX
Tags LLY BIIB SPX
From MarketWatch
Biotech Is Back With Guggenheim Upgrade: What You Need To Know
Tickers BIIB
Tags Biotech Mid Cap BIIB
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
Tickers ALHC ARBK ARCB AVB
Tags Initiation PFG BIRD
From Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.